Objective: To examine the contribution of the Addenbrooke's Cognitive Examination (ACE), neuropsychological assessment, and a magnetic resonance imaging (MRI)-based temporal lobe rating scale to the prediction of which patients with questionable dementia will progress to Alzheimer's disease (AD).
T he recent advances in the characterization of the early clinical features of Alzheimer's disease (AD) have highlighted the impairments in cognition that occur before fulfillment of the criteria for a dementing illness. This prodromal stage of AD affects mainly episodic memory and can remain stable for several years. 1, 2 There have been many attempts to encompass the predementia phase of AD within such rubrics as mild cognitive impairment (MCI), 3 questionable dementia, 4 and minimal dementia. 5 In this study, the term ''questionable dementia'' (QD) was used to define patients presenting with significant subjective memory complaints to a memory clinic (with or without impairment on cognitive tests) in the absence of a neurologic or psychiatric diagnosis. This broad definition was chosen to be practically relevant to the clinical population of elderly subjects presenting at a memory clinic.
The earliest pathologic changes in AD involve the medial temporal lobe [6] [7] [8] corresponding to the early episodic memory impairments. [9] [10] [11] Neuroimaging studies have therefore focused on detecting atrophy in the hippocampus and medial temporal lobe in the earliest stages of AD. Several groups have examined the hippocampal atrophy profile in MCI patients and compared it with that in normal elderly and AD subjects, [12] [13] [14] [15] [16] although longitudinal follow-up was lacking in the majority of these studies. Later work has followed up MCI patients to onset of dementia [17] [18] [19] with variable results for the prediction of AD and are discussed more fully below.
Imaging studies attempting to improve the reliable early diagnosis of AD have concentrated on MRI measures, but there is, as yet, limited evidence that imaging is of benefit in the early diagnosis, over and above neuropsychological measures. This is of particular relevance because our recent findings have demonstrated the extremely high accuracy of certain neuropsychological approaches. 20 As yet, however, there has been little work comparing the relative sensitivity of imaging methodologies and other neuropsychological diagnostic procedures. Visser and colleagues 19 compared medial temporal lobe rating scales, volumetric analysis, and the memory subscore from the cognitive component of the Cambridge Examination for Mental Disorders in the Elderly (CAMCOG) using logistic regression to determine progression from minimal dementia to AD in 20 patients (rate of conversion 45% in 3 years). As a single variable, the memory score was the best predictor (88% correctly classified); adding the parahippocampal volume or medial temporal lobe rating scale improved this to 96% correct classification. More recently, Laakso et al 21 compared a visual reproduction task and hippocampal volumes in 57 AD patients and 34 control subjects and found that neuropsychological tests provided better discrimination between the groups than the hippocampal volumes. Examining subjects at risk for autosomal dominant AD, Fox and co-workers 22 found that subjects at risk for familial AD who went on to dement had an increased rate of brain atrophy when the only cognitive abnormality was impaired verbal recognition memory.
The 100-item Addenbrooke's Cognitive Examination (ACE) was designed for use in a broad range of clinical settings because it does not require specialized equipment, takes only 10-15 minutes to complete, and incorporates the MiniMental State Examination (MMSE). An initial study of 250 clinic attendees and 127 control subjects showed it to be able to discriminate AD from frontotemporal dementia and suggested that it might be highly sensitive in early AD. 23 It has not, however, been evaluated prospectively in patients with prodromal AD or compared systematically with conventional neuropsychological tests and/or MRI-based temporal lobe evaluation.
The aim of this study was to address the relative value of the ACE and more detailed standard neuropsychological tests of cognitive function and evaluation of the medial temporal lobe in predicting progression to AD. This question was addressed in a longitudinal follow-up study with MRI neuroimaging at baseline.
METHODS

Patient Group
A total of 50 subjects participated: 19 with mild AD and 31 with QD. The subjects in this study were a subgroup of the 23 AD and 43 QD patients recruited from the Memory Clinic in Addenbrooke's Hospital, Cambridge, for a longitudinal project, 24 who had undergone suitable MRI imaging at entry (V1 = first visit). The remaining patients (AD = 4, QD = 12) were unable to undergo MRI for a variety of reasons including claustrophobia or pacemakers. Consecutive referrals were approached and screened to exclude extrapyramidal signs or hallucinations, vascular dementia, current cancer treatment, uncontrolled diabetes, and serious head injury. Patients with cerebrovascular events, epilepsy, and major depression were excluded. All subjects were aged between 50 and 80 years at the time of recruitment (1997) (1998) (1999) . None was being treated with anticholinesterase inhibitor therapies at the start of the project. The study was approved by the local ethical committee, and informed consent was obtained from the patients and relatives prior to inclusion in the study.
The AD group comprised patients with mild to moderate probable AD (mean MMSE 21.4, SD 2.6) who fulfilled National Institute of Neurological and Communication Disorders and Stroke (NINCDS)/Alzheimer's Disease and Related Disorders Association (ADRDA) criteria, scored above 17 on the MMSE 25 at entry, and in whom the diagnosis was confirmed clinically at follow-up. The majority of AD patients subsequently received anticholinesterase inhibitor therapies after diagnosis. Patients with QD met the following criteria: (a) subjective complaints of memory impairment substantiated by an informant, (b) normal activities of daily living, and (c) nondemented as evident from an MMSE score of $23. Of note is the fact that level of performance on memory tests was not used because there is no generally agreed gold standard for the classification of impairment. Such patients correspond to mild cognitive impairment (MCI) as defined by some groups of workers using the Clinical Dementia Rating Scale 26 (CDR) but not by those who base the diagnosis of MCI on neuropsychological test performance. 3 On CDR rating, all patients had an equivalent of a score of 0.5.
The QD group were subsequently subdivided according to follow-up clinical data at their fourth visit (V4; 24.2 months, SD 5.4 months) into converters and nonconverters. The subjects in the QD group who had deteriorated to meet NINCDS/ADRDA criteria for probable AD 27 at the V4 follow-up were termed converters (n = 11). Onset of dementia was determined on functional grounds after interview and examination of the patient and family members and was independent of the neuropsychological and imaging findings. In terms of CDR score, conversion to dementia was equivalent to a change from 0.5 to 1.0 or greater. Two subjects in the QD group were diagnosed with dementia with Lewy bodies at V4 and have been excluded from the analyses, leaving 18 nonconverters. There were also two deaths by V4 (from the AD group).
The demographic data on the subjects are shown in Table 1 . It should be noted that there are more women in the AD group than the other two groups; there was no significant difference in age between the AD and converter groups, but these two were significantly older than the nonconverter group. The AD group had a lower predicted IQ relative to the other two groups. All the groups differed on MMSE (P , 0.0005), the AD group having the lowest scores with a mean of 21.4 (range 26-16). 
Neuropsychological Measures
The subjects were tested longitudinally at baseline (V1), 8 months (V2), 16 months (V3), and 24 months (V4) by a psychologist in their own homes. Only the baseline assessments (V1) are reported here. A battery of standardized neuropsychological tests was given to investigate the following domains.
General Measures
1. ACE 23 and Alzheimer's Disease Assessment Scale cognitive section (ADAS-cog). 28 The ACE consists of five subsections: orientation and attention (from MMSE), verbal fluency (animals and words beginning with P), language (12-item naming test, comprehension of sentences, repetition, reading and writing a sentence), memory (3 items from MMSE, name and address learning, recall, naming of four personalities), and visuospatial abilities (pentagons from MMSE, wire cube copy, and clock drawing test). Total score = 100. Time to complete 10-15 minutes. 
Episodic Memory
Executive Function
Letter fluency for words beginning with the letter F, A, and S.
Imaging and Rating Scale
The majority of MRI scans (n = 33; 66%) were performed according to the protocol (three-dimensional spoiled gradient-recalled T1-weighted sequence) previously described, 33 although 34% (n = 17) of subjects were scanned before the introduction of this protocol; but in all cases, coronal T1 films were available for rating. Of the 17 scans performed using this second sequence, 8 were in the AD group and 9 were from the QD group. The 50 coronal films were blinded and randomized. They were assessed in two sessions (to maintain concentration) using the Temporal Lobe Rating Scale described and validated previously. 33 In brief, the scale builds upon the Scheltens Hippocampal Scale 19, 34 but incorporates temporal pole, parahippocampal region (based on expansion of the collateral sulcus) and the inferolateral temporal region. Each region is related with reference to a template on a 4-point scale (0 = normal, 1 = mild, 2 = moderate, 3 = severely abnormal). Previous studies have shown reliability when scores are dichotomized as normal or questionable (0-1) versus abnormal (2-3).
19,33
Statistical Method
All statistics were performed using SPSS 10.0 for Macintosh. The neuropsychological tests were compared between groups using a one-way analysis of variance and Tukey posthoc tests. The rating scales were compared between groups using nonparametric tests (Kruskal-Wallis, x 2 or Mann-Whitney as appropriate). Sensitivity, specificity, positive predictive value, and negative predictive values were calculated using a separate discriminant function analysis for each variable comparing converting and nonconverting QD groups.
Predictive values measure how useful the test is in practice. The positive predictive value (PPV) is the probability of actually having the condition with a positive test result, whereas the negative predictive value (NPV) is the probability of not having the disease when the test is negative. Sensitivity measures the number of cases correctly diagnosed, and specificity measures the proportion of subjects without disease correctly diagnosed. 35 
RESULTS
Neuropsychological Results
As shown in Table 2 , comparison of the baseline data in the AD, converter, and nonconverter groups showed a significant overall group difference on all measures (P , 0.05). Pairwise post-hoc analyses confirmed that the AD group performed poorly on all measures compared with the nonconverter QD group. The AD and converter groups performed similarly on some tests, but on others (the ADAS-cog, ACE, Doors, category fluency, Graded Naming Test, and letter fluency), the AD group was more impaired than the converters. Figure 1 illustrates the ratings for each of the regions with scores dichotomized as normal or questionable (0-1) versus abnormal (2-3). For the temporal pole and inferolateral temporal region, virtually all patients had normal ratings, and statistical comparisons revealed no overall group differences. Intergroup analyses focused, therefore, upon the hippocampal and parahippocampal ratings. For the hippocampi, more than 85% of nonconverters had normal hippocampi (0-1). Conversely, the majority of converters and AD patients had abnormal hippocampal ratings. Statistical analysis using the dichotomized scores confirmed a significant effect of group for both left (Kruskal-Wallis: x 2 = 12.2, df = 2, P = 0.002) and right (Kruskal-Wallis: x 2 = 20.4, df = 2, P , 0.001) hippocampi. The results of pairwise post-hoc comparisons (MannWhitney U tests) using the dichotomized variables are shown in Table 3 . In terms of prediction, the critical difference was between converter and nonconverter groups, which differed significantly on both right and left hippocampal scores. Results were identical if combined scores for left plus right sides were considered, giving a range of scores of from 0 to 6, dichotomized as 0-2 = 1 and 3-6 = 2. In summary, degree of atrophy was AD = converters . nonconverters.
Imaging Results
For the parahippocampal region, a smaller proportion of AD and converters had abnormal ratings (25-40%; see Figure  1 ) with no appreciable difference between these two groups.
Virtually all of the nonconverters had normal ratings. Statistical analysis revealed a significant (P exact, two tailed) effect of group for the left side (Kruskal-Wallis: x 2 = 7.8, df = 2, P , 0.02) but not for the right (Kruskal-Wallis: x 2 = 3.2, df = 2, P = 0.199). However, pairwise comparisons (see Table 3 ) showed no significant differences between all three groups, although there was a trend toward significance between AD and nonconverters. This was also the case when combined scores for left and right sides were considered.
Prediction of Progression to AD
The test with the best combination of sensitivity and PPV was the ACE score; this was the only measure with a PPV of 100% and (as shown in Table 4 ) the specificity was also very high (100%). From the scatterplot of ACE score shown in Figure 2 , it can be seen that a cut-off score of 80 provides the best separation of the converters and nonconverters. The logical memory scores and the right hippocampal and left parahippocampal ratings produced even better sensitivities (over 90%) than the ACE but much poorer PPVs: Although converters were well predicted by these tests, an abnormal test score was not restricted to converters. The recognition tests (Recognition Memory Tests and Doors Tests) had poorer sensitivities but generally similar or slightly worse PPVs.
A stepwise discriminant analysis of the QD group including only the neuropsychological measures (and age and sex) confirmed that the best predictor of conversion to AD was provided firstly by the ACE score (F = 37.81; df = 1, 27; P , 0.001) followed by age (F = 26.99; df = 2, 26; P , 0.001), and logical memory (delayed recall) (F = 21.27; df = 3, 25; P , 0.001). This combination correctly classified 93.1% of the group.
With use of only the imaging variables (and age and sex), a combination of the right hippocampus (F = 34.28; df = 1, 27; P , 0.001) and left parahippocampus (F = 20.97; df = 1, 26; P , 0.001) ratings correctly classified 89.7% of the cases. When both the neuropsychological and the imaging variables (plus sex and age) were used, the ACE was still found to be the best discriminator, and a combination of the ACE (F = 37.81; df = 1,27; P , 0.001), right hippocampal rating (F = 27.77; df = 2, 26; P , 0.001), and letter fluency (F = 24.281; df = 3, 25; P , 0.001) correctly classified 93.1% of the cohort.
DISCUSSION
We have confirmed prior studies showing that the medial temporal lobe is more atrophied in those subjects at risk for dementia who subsequently convert to presumed AD. The ACE was, however, the best single predictor of progression to AD.
The sensitivity of the ACE almost certainly reflects the fact that it contains tests of both episodic and semantic memory, both of which are known to be impaired very early in the course of AD. Although subjects who later converted to AD were indistinguishable from those with established AD, even at baseline assessment, on tests of episodic memory (story recall and the Recognition Memory Tests), these tests were not, when considered alone, good predictors: The Story Recall Task, although highly sensitive, lacked specificity and PPV owing to variable performance in nonconverters. By contrast, the Recognition Memory Test, although highly specific, showed poor sensitivity. Converters also showed deficits in semantic memory, as reflected by their impairment on two tests sensitive to semantic memory, category fluency, and the Graded Naming Test (GNT), but again neither test alone produced levels of PPVs and NPVs equivalent to those of the ACE.
Several MCI volumetric studies have followed up MCI patients to examine predictors of conversion to AD. [17] [18] [19] These studies had similar rates of conversion (24-40%) with an average of 3 years of clinical follow-up but report variable ability to reliably discriminate early AD from normal aging. 17, 18, 36, 37 Our study has a conversion rate of 37.5% (12/32) to AD, but an additional 2 patients developed dementia with Lewy bodies, making the overall conversion rate to dementia 44% (14/32) in 24 months, which is comparable with the published literature. The variable ability to discriminate prodromal AD from normal aging in these imaging studies may be explained by technical differences between the methods employed. Convit and colleagues, 17 using regression analyses, found that a composite of hippocampus and parahippocampal gyrus volumes had a relatively low sensitivity of detecting prodromal AD of 57%. Adding other temporal regions into the model increased the sensitivity to 93%. No other clinical baseline variables had a sensitivity above 71%, although, of note, the cognitive tests used were limited. The authors concluded that the temporal association cortex may be the first nonhippocampal region involved in AD. In another recent study using both manual tracing and semiautomated regions of interest, the discrimination of normal elderly subjects from those with prodromal AD was found to be 93% (sensitivity 95%, specificity 90%): The volume of the entorhinal cortex and the banks of the superior temporal sulcus were the areas that discriminated best between the groups. 37 The Mayo Clinic group found that decline in hippocampal volume was associated with increased risk of AD, but this was not very predictive (relative risk 0.69). 18 Fox et al 22 used serial coregistration to measure the rate of atrophy of the whole brain in subjects at risk for familial AD and found a significantly increased rate of atrophy compared with control subjects.
Comparing traditional pencil-and-paper neuropsychological tests and imaging predictors of progression to AD, several points are of interest. First, the ACE score best predicted those with incipient AD. This confirms that composite tests such as the ACE are more useful in clinical practice than any single traditional imaging measure based on pencil-andpaper neuropsychological test or rating scale. A direct comparison of specific episodic memory tests and the measures of medial temporal lobe atrophy revealed that logical memory (story recall) and some of the imaging scores were equivalent in terms of sensitivity and specificity. The Recognition Memory Tasks had poorer discriminant value than the imaging measures. A study similar to ours employed both medial temporal lobe rating measures, volumetric analysis of the hippocampus, parahippocampal gyrus, and lateral temporal lobe, and the CAMCOG score to predict conversion to AD. 19 As in our study, the single best predictor of conversion to AD was a composite cognitive measure (memory subscore of the CAM-COG). Adding the parahippocampal volume (or the rating score of hippocampal atrophy) similarly improved the diagnostic accuracy. Second, cognitive deficits in the converters were not confined to the domain of episodic memory. The measures of semantic memory (category fluency and naming) were also fairly sensitive but lacked the predictive value of the logical memory or the ACE.
Naming and word-finding difficulties are prominent early in AD. 10, 38 A pathologic study of patients with very mild AD demonstrated that subjects with QD (CDR = 0.5) had worse performance on the Boston Naming Test than subjects with subclinical AD (CDR = 0), implying naming is sensitive to early pathologic changes of AD. 39 This finding was, however, not confirmed in another longitudinal study of dementia prediction where the Boston Naming Task was not a significant predictor of decline to AD. 40 Of note is the finding that a combination of the ACE, age, and logical memory (delayed) was able to correctly classify 93% of the questionable group. The MRI-based rating scale, when used alone, was inferior to the neuropsychological tests but when used together with the ACE produced a level of discrimination equivalent to that of the neuropsychological battery: For all rating variables, ACE, age, and sex, the combination of ACE and right hippocampus rating correctly classified 96.6% of the QD group.
One confounding factor in our study was the use of the MMSE to define the QD group (score $23) as it is also part of the ACE. The ACE was designed to incorporate the MMSE because this is such a universally used clinical measure. Onset of dementia in the QD group was, however, determined by a change in functional ability with an increase on the CDR from 0.5 to 1.0 or greater. In the tertiary referral situation, a good diagnostic test for AD requires particularly high sensitivity and PPV. False positives in the diagnosis of AD may be more unacceptable than false negatives.
In conclusion, although the concept of dementia, as encompassed by NINCDS/ADRDA criteria, is unquestionably outdated, defining AD at the earliest stage of disease is still a considerable challenge in clinical practice. The results of this analysis, together with our other recent findings, 20 suggest that neuropsychological approaches to the early detection of AD and the differential diagnosis of depression are still the most sensitive and clinically viable. Further large-scale longitudinal studies are required, which compare directly neuropsychological imaging and biomarkers of dementia.
